Innovative MedTech company Tarilian Laser Technologies (TLT) and its newly formed consumer division ViCardio Ltd have been recognised at two prestigious events. Both awards highlighted the unique power of Tarilian Laser Technologies’ innovative biosensor platform and its new consumer product ViCardio® , the world’s first non-invasive, beat-to-beat, high performance blood pressure monitor.
Global accountancy giant PwC awarded TLT a place in the ‘Great Festival of Innovation’ which will take place in Hong Kong during 21-24 March 2018.
TLT have been named as one of six finalists whose video stories will be featured at the festival, which is organised by the UK Government’s Department for International Trade and the Prime Minister’s Office.
Speaking for TLT, Dr Sandeep Shah (CEO) says:
“It is a real honour for TLT to be given this recognition by PWC and the DIT. Our work over the last few years to develop a unique continuous, beat-to-beat, cuffless, blood pressure sensor and monitor is a paradigm shift in how this crucial physiological measurement of health is achieved.
This is of global importance to healthcare providers and patients, cialis tadalafil, as well as offering a major opportunity for British exports. We are very proud to be one of six companies chosen by PwC to represent Great British Innovation.”
Details of the award can be found at: https://tinyurl.com/tltgreat
In a second event, the Future Healthcare 2018 Conference and Exhibition held at London’s Olympia on the 12t h /13t h March, ViCardio Ltd was recognised in an award for the ‘Best Innovator’, following a ‘Dragons Den’ style pitch to a panel of globally recognised judges.
Representing ViCardio Limited, Dr David Pearce addressed the panel with regards to the current inadequacies of both current cuff based devices and any other credible emerging technologies. He emphasised the important breakthrough of the Tarilian Laser Technologies (TLT) sensor. This is a unique, patented, opto-electronic, micro-motion sensor, which is central in allowing ViCardio® to be the world’s first non-invasive, beat-to-beat, blood pressure monitor.
Dr Pearce commented:
“The TLT Blood Pressure Sensor represents one of the most relevant and exciting breakthroughs in Medical Sensor Technology. Blood pressure is one of the most fundamental and frequently measured parameters of human health from the Intensive Care setting right through to the patient at home. The ability to take frequent accurate* beat-to-beat readings is simply an enormous paradigm shift for professionals and consumers world-wide
João Bocas, Chairman and Panel judge, and recognised expert on medical wearable technology, said:
“The innovators pitched to us, the standard of innovation was extremely high. We’ve had innovations from all over the world. The judges very soon realised that ViCardio® was something special, furthermore addressing a colossal problem with their unique and reliable device. Therefore we selected ViCardio® as the winner.”
For further details on the Great Festival of Innovation, please see:
*All claims of accuracy are subject to, and will in due course be certified to, an international recognised medical grade approved standard. The TLT sensor is undergoing strict regulatory clinical testing to the highest standards, with CE Mark and FDA regulatory filings to follow.